tirzepatide use during pregnancy Weight Loss Medication and Pregnancy: Is It Safe? | Obesity Medicine Association GLP-1 Weight Loss and Transition

But smaller vendors who take the same risks simply have not attracted the same level of scrutiny yet

(1998) showed that Ipamorelin does not significantly elevate cortisol, prolactin, or ACTH at GH-effective concentrations

Communication with your healthcare team about symptom severity and impact on daily functioning is essential for optimizing your treatment plan

That breaks down to 100 million adults being obese and more than 22 million being severely obese

Key Takeaways Tirzepatide vs semaglutide comes down to dual agonist vs single agonist: tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone The only head-to-head trial (SURPASS-2) found tirzepatide superior to semaglutide for both blood sugar control and weight loss In separate obesity trials, tirzepatide 15mg achieved 20.9% weight loss at 72 weeks vs semaglutide 2.4mg's 14.9% at 68 weeks Semaglutide has proven cardiovascular benefit (SELECT trial: 20% MACE reduction)

doi: 10.1007/s11154-019-09511-1 101 ShackleyMMaYTateEWBrownAJHFrostGHanyalogluAC